USE OF BEDAQUILINE IN THE CHEMOTHERAPY REGIMEN FOR MULTIPLE DRUG RESISTANT TUBERCULOSIS IN THE HIV POSITIVE PATIENT
Наталья Давыдовна Пирогова, S. N. LESHOK, L. V. SCHIPUNOVА, N G Beloborodova
Tuberculosis and lung diseases · 2019-01
Abstract
The article describes a clinical case of the effective treatment of multiple drug resistant respiratory tuberculosis in the HIV positive patient. The chemotherapy regimen consisted of 5 anti-tuberculosis drugs, including bedaquiline, and 3 antiretroviral (ARV) drugs. The combined use of bedaquiline and ARV therapy did not result in any adverse reactions.
MeSH terms
- Bedaquiline
- Medicine
- Regimen
- Tuberculosis
- Human immunodeficiency virus (HIV)
- Drug
- Adverse effect
- Chemotherapy
- Internal medicine
- Chemotherapy regimen